4-Fluoro-3H-spiro[2-benzofuran-1,4'-piperidine] hydrochloride
95%
- Product Code: 75565
CAS:
1779129-96-2
| Molecular Weight: | 243.17 g./mol | Molecular Formula: | C₁₂H₁₅ClFNO |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD27995750 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structural features make it valuable in the design of compounds that interact with specific receptors in the brain, potentially aiding in the treatment of conditions like depression, anxiety, and schizophrenia. Additionally, its spirocyclic and fluorinated components enhance its metabolic stability and binding affinity, making it a promising candidate for drug discovery programs focused on central nervous system therapies. Researchers also explore its application in creating novel therapeutic agents with improved efficacy and reduced side effects.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | Ft2,286,588.94 |
+
-
|
4-Fluoro-3H-spiro[2-benzofuran-1,4'-piperidine] hydrochloride
This compound is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various bioactive molecules, particularly those targeting neurological disorders. Its structural features make it valuable in the design of compounds that interact with specific receptors in the brain, potentially aiding in the treatment of conditions like depression, anxiety, and schizophrenia. Additionally, its spirocyclic and fluorinated components enhance its metabolic stability and binding affinity, making it a promising candidate for drug discovery programs focused on central nervous system therapies. Researchers also explore its application in creating novel therapeutic agents with improved efficacy and reduced side effects.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :